| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 63.232 | 75.702 | 88.085 | 90.170 | 96.111 | 118.639 | 155.335 | 171.627 | 163.517 | 174.434 |
| Total Income - EUR | 64.716 | 76.015 | 89.464 | 91.138 | 96.514 | 118.643 | 155.336 | 171.639 | 166.182 | 178.196 |
| Total Expenses - EUR | 67.139 | 44.383 | 54.655 | 51.588 | 41.949 | 35.402 | 38.884 | 28.873 | 36.200 | 43.784 |
| Gross Profit/Loss - EUR | -2.423 | 31.632 | 34.809 | 39.550 | 54.564 | 83.241 | 116.452 | 142.766 | 129.982 | 134.412 |
| Net Profit/Loss - EUR | -2.423 | 30.874 | 33.928 | 38.648 | 53.599 | 82.140 | 114.982 | 141.084 | 128.363 | 129.869 |
| Employees | 4 | 3 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Med Love S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 72.433 | 67.074 | 48.457 | 25.920 | 14.312 | 2.382 | 7.354 | 15.490 | 26.752 | 22.871 |
| Current Assets | 7.319 | 9.796 | 9.312 | 72.536 | 64.602 | 102.396 | 130.387 | 147.627 | 172.334 | 274.717 |
| Inventories | 888 | 879 | 2.727 | 2.677 | 3.868 | 3.794 | 3.710 | 4.096 | 4.083 | 4.060 |
| Receivables | 3.812 | 7.263 | 3.986 | 3.933 | 40.098 | 37.828 | 58.608 | 115.517 | 9.577 | 7.441 |
| Cash | 2.619 | 1.654 | 2.599 | 65.926 | 20.636 | 60.773 | 68.068 | 28.015 | 158.674 | 263.215 |
| Shareholders Funds | 16.193 | 46.902 | 36.485 | 74.463 | 53.650 | 82.190 | 115.031 | 141.133 | 128.412 | 170.157 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 63.559 | 29.968 | 21.284 | 23.993 | 25.264 | 22.588 | 22.710 | 21.985 | 70.675 | 127.431 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Med Love S.r.l.